Syneron Medical Ltd. is proud to announce it has received United States Food and Drug Administration (FDA) clearance for elōs Plus™, a next generation multi-platform system featuring the Company’s proprietary elōs technology. The FDA clearance for elōs Plus follows on the recent international launch in Europe and Asia.
New Advances in Treating Hyperpigmentation
This past decade has seen an enormous surge in popularity of skin brightening products formulated specifically to treat hyperpigmentation and…


0 Comments